Cutting-Edge Biotech Firm Chooses Albany for First US Expansion

One Biosciences, a Paris-based company using AI to research cancer treatments, will open at Albany College of Pharmacy and Health Sciences.

Apr. 17, 2026 at 10:19pm

Got story updates? Submit your updates here. ›

A highly detailed, translucent X-ray image showing the intricate internal structure of a cancer cell, with glowing lines and shapes against a dark background, conveying the complexity of tumor biology.A cutting-edge biotech firm's move to Albany signals the state's growing strength in life sciences research and development.Albany Today

A cutting-edge biotech firm that uses AI to research cancer treatments has chosen Albany, New York as the location for its first home outside of Paris. One Biosciences will be located at the Albany College of Pharmacy and Health Sciences, bringing 42 new jobs and a $18 million investment to the area over the next five years.

Why it matters

The decision by One Biosciences to expand to Albany highlights the city's growing reputation as a hub for life sciences research and development. The company's focus on precision medicine and use of AI to inform cancer treatment could lead to significant advancements in patient care.

The details

One Biosciences, an executive chair said, was born out of the challenge of certain types of cancer not having great treatments, while other treatments work well for some patients but not others. The company uses AI to source data from multiple public sources to build models showing how cell types act, which they then layer over their own research to better understand tumor biology and inform clinical care and trials.

  • One Biosciences will be opening its Albany location in the coming months.
  • The company plans to invest $18 million into the Albany location over the next five years.

The players

One Biosciences

A cutting-edge biotech firm based in Paris that uses AI to research cancer treatments.

Albany College of Pharmacy and Health Sciences

The institution where One Biosciences will be located for its first US expansion.

Governor Kathy Hochul

The Governor of New York who stressed the importance of life sciences research and development in the state.

Empire State Development

The organization that helped facilitate One Biosciences' entry into the US, offering $525,000 in state tax credits.

Regeneron

A biotech company located near Albany that was cited as a compelling reason for One Biosciences to expand to the area.

Got photos? Submit your photos here. ›

What they’re saying

“'Certain types of cancer don't have great treatments, of course, and then in other types, we see a treatment that works exceptionally well in some patients, but not well in others.'”

— One Biosciences Executive Chair

“'And so being able to look at the RNA of a tumor on a cellular level really puts a powerful lens on the tumor biology and we believe will much more greatly inform our understanding of what happens in clinical care, clinical trials, etc.'”

— One Biosciences Executive Chair

“'not only grow here, but that the next generation of medical breakthroughs happen in New York State.'”

— Governor Kathy Hochul

“'Being, you know, not too far from Boston, not too far from New York, having companies like Regeneron just a short drive away, is very compelling for building relationships that foster this trust and ultimately lead to more studies, more observations, and ultimately things that reach the patient.'”

— One Biosciences Executive Chair

What’s next

One Biosciences is expected to open its new Albany location in the coming months and plans to invest $18 million into the site over the next five years.

The takeaway

The decision by One Biosciences, a cutting-edge biotech firm using AI to research cancer treatments, to expand to Albany highlights the city's growing reputation as a hub for life sciences innovation. The company's focus on precision medicine could lead to significant advancements in cancer care, while also bringing new jobs and investment to the region.